23994-20-9 Usage
Uses
Used in Pharmaceutical Industry:
4-Chloroisoquinoline-1-carbonitrile is used as a key intermediate in the synthesis of biologically active compounds due to its reactivity and structural features that facilitate the creation of diverse pharmaceutical agents.
Used in Agrochemical Development:
In the agrochemical industry, 4-Chloroisoquinoline-1-carbonitrile is utilized as a precursor in the development of herbicides and insecticides, capitalizing on its chemical properties to enhance crop protection and management strategies.
Used in Organic Synthesis:
4-Chloroisoquinoline-1-carbonitrile is employed as a versatile building block in organic synthesis for the construction of complex organic molecules, taking advantage of its ability to undergo various chemical reactions to form desired products.
Check Digit Verification of cas no
The CAS Registry Mumber 23994-20-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,9,9 and 4 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 23994-20:
(7*2)+(6*3)+(5*9)+(4*9)+(3*4)+(2*2)+(1*0)=129
129 % 10 = 9
So 23994-20-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H5ClN2/c11-9-6-13-10(5-12)8-4-2-1-3-7(8)9/h1-4,6H
23994-20-9Relevant academic research and scientific papers
HCV NS5A replication complex inhibitors. Part 4.1 optimization for genotype 1a replicon inhibitory activity
St. Laurent, Denis R.,Serrano-Wu, Michael H.,Belema, Makonen,Ding, Min,Fang, Hua,Gao, Min,Goodrich, Jason T.,Krause, Rudolph G.,Lemm, Julie A.,Liu, Mengping,Lopez, Omar D.,Nguyen, Van N.,Nower, Peter T.,O'Boyle, Donald R.,Pearce, Bradley C.,Romine, Jeffrey L.,Valera, Lourdes,Sun, Jin-Hua,Wang, Ying-Kai,Yang, Fukang,Yang, Xuejie,Meanwell, Nicholas A.,Snyder, Lawrence B.
, p. 1976 - 1994 (2014/04/03)
A series of symmetrical E-stilbene prolinamides that originated from the library-synthesized lead 3 was studied with respect to HCV genotype 1a (G-1a) and genotype 1b (G-1b) replicon inhibition and selectivity against BVDV and cytotoxicity. SAR emerging f
